Macular function impairment in eyes with early age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 2, 1997, Pages 469-477

  Midena, Edoardo ^a   Angeli, Claudia Degli ^a   Blarzino, Maria C ^a   Valenti, Massimo ^a   Segato, Tatiana ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

age related macular degeneration; automated perimetry; color vision; contrast sensitivity; dark adaptation

Indexed keywords

ADULT; AGING; ARTICLE; CLINICAL ARTICLE; COLOR VISION; CONTRAST SENSITIVITY; CONTROLLED STUDY; DARK ADAPTATION; FLUORESCENCE ANGIOGRAPHY; HUMAN; OPHTHALMOSCOPY; PERIMETRY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; VISION TEST; VISUAL ACUITY; VISUAL FIELD;

AGED; COLOR PERCEPTION; CONTRAST SENSITIVITY; DARK ADAPTATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; MALE; MIDDLE AGED; VISUAL ACUITY; VISUAL FIELDS;

EID: 1842338077     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Leibowitz HM, Krueger DE, Maunder LR et al. The Framingham Eye Study Monograph. Surv Ophthalmol. 1980;24(suppl):S35-610.
2. Ferris FL III Senile macular degeneration: review of epidemiologic features. Am J Epidemiol. 1983;118:132-151.
3. Pauleikhoff D, Barondes MJ, Minassian D, Chisholm IH, Bird AC. Drusen as risk factors in age-related macular disease. Am J Ophthalmol. 1990;109:38-43.
4. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
5. Vingerling JR, Dielemans I, Hofman A et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102:205-210.
6. Macular Photocoagulauon Study group Argon laser photocoagulation for senile macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1982;100:912-918.
7. Macular Photocoagulation Study group Argon laser photocoagulation for neovascular maculopathy: three-year results from randomized clinical trial. Arch Ophthalmol. 1986;104:694-701.
8. Macular Photocoagulation Study group Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1990;108:816-824.
9. Macular Photocoagulation Study group Argon laser photocoagulation for neovascular maculopathy. Five years results from randomized clinical trial. Arch Ophthalmol. 1991;109:1109-1114.
10. Macular Photocoagulation Study group Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109:1220-1231.
11. Macular Photocoagulation Study group Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study group. Arch Ophthalmol. 1991;109:1242-1257.
12. Macular Photocoagulation Study group Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: findings from two clinical trials. Arch Ophthalmol. 1993;111:1200-1209.
13. Gregor Z, Bird AC, Chisholm IH. Senile disciform macular degeneration in the second eye. Br J Ophthalmol. 1977;61:141-147.
14. Strahlman E, Fine SL, Hillis A. The second eye of patients with senile macular degeneration. Arch Ophthalmol. 1983;101:1191-1193.
15. Smiddy WE, Fine SL. Prognosis of patients with bilateral macular drusen. Ophthalmology. 1984;91:271-277.
16. Bressler NM, Bressler SB, Seddon JM, Gragoudas ES, Jacobson LP. Drusen characteristics in patients with exudative versus nonexudative age-related macular degeneration. Retina. 1988;8:109-114.
17. Bressler SB, Maguire MG, Bressler NM, Fine SL. The Macular Photocoagulation Study group. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol 1990;108:1442-1447.
18. Sarks JP, Sarks SH, Killingsworth MC. Evolution of soft drusen in age-related macular degeneration. Eye. 1994;8:269-283.
19. Bressler NM, Silva JC, Bressler SB, Fine SL, Green WR. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina. 1994;14:130-142.
20. Ferris FL III, Kassof A, Bresnick G, Bailey I. New visual acuity Charts for clinical research. Am J Ophthalmol. 1982;94:91-96.
21. Early Treatment Diabetic Retinopathy Study Manual of Operations. Baltimore, ETDRS Coordinating Center, Department of Epidemiology and Preventive Medicine, 1980; ch. 12, pp. 1-15
22. Midena E, Segato T, Giuliano M, Zucchetto M. Macular recovery function (Nictonietry) in diabetics without and with early retinopathy. Br J Ophthalmol. 1990;74:106-108.
23. Farsworth D. The Farnsworth-Munsell 100 Hue Test Manual. Kollmorgen Corporation. 2441 North Calvert Street, Baltimore, Maryland, 1957.
24. Smith VC, Pokornj J, Pass AS. Color axis determination on the Farnsworth-Munsell 100 Hue Test. Am J Ophthalmol 1985;100:176-182.
25. Verriest G, Van Laethem J, Uvijls A. A new assessment of the normal ranges of the Farnsworth-Munsell 100 Hue Test scores. Am J Ophthalmol. 1982;93:635-642.
26. Amsler Charts Manual. Keeler Limited. Clewer Hill Road, Windsor, Berkshire, UK.
27. Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR. The grading and prevalence of macular degeneration in Chesapeake Bay Watermen. Ophthalmology. 1989;107:847-852.
28. Wisconsin Age-Related Maculopathy Grading System. Madison, Department of Ophthalmology, University of Wisconsin School of Medicine 1991. Available from: National Technical Information Service, 5285 Port Royal Rd. Springfield, VA 22161.
29. The International ARM Epidemiological Study group. An international classification and grading system for age-related maculopathy and age-related macular degeneration Surv Ophthalmol. 1995;39:367-374.
30. Collins M, Brown B. Glare recovery and age-related maculopathy. Clin Vision Sci. 1989;4:145-153.
31. Sjostrand J, Friśen L. Contrast sensitivity in macular disease. A preliminary report. Acta Ophthalmol. 1977; 55:507-513.
32. Wolkstein M, Atkin A, Bodis-Wollner I. Contrast sensitivity in retinal disease. Ophthalmology. 1980;87:1140-1149.
33. Kleiner RC, Enger C, Alexander MF, Fine SL. Contrast sensitivity in age-related macular degeneration. Arch Ophthalmol. 1988;106:55-57.
34. Brown B, Adams AJ, Coletta NJ, Haegerstrom-Portnoy G. Dark adaptation in age-related maculopathy. Ophthal Physiol Opt. 1986;6:81-84.
35. Wu G, Weiter JJ, Santos S, Ginsburg L, Villalobos R. The Macular Photostress Test in diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol 1990;108:1556-1559.
36. Gaudio AR, Sandberg MA. The clinical significance of slow dazzle recovery in age-related macular degeneration. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1995;36:S233.
37. Eisner A, Fleming SA, Klein ML, Mauldin WM. Sensitivities in older eyes with good acuity: eyes whose fellow eye has exudative AMD. Invest Ophthalmol Vis Sci. 1987;28:1832-1837.
38. Eisner A, Stoumbos VD, Klein ML, Fleming SA. Relations between fundus appearance and function. Eyes whose fellow eye has exudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 1991;32:8-20.
39. Steinmetz RL, Haimovici R, Jubb C, Fitzke FW, Bird AC. Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol. 1993;77:549-554.
40. Midena E, Segato T, Blarzino MC, Degli Angeli C. Macular drusen and the sensitivity of the central visual field. Doc Ophthalmol. 1994;88:179-185.
41. Eisner A, Stoumbos VD, Klein ML, Fleming SA. Relation between fundus appearance and function: eyes whose fellow eye has exudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 1991;32:8-20.
42. Chen JC, Fitzke FW, Pauleikhoff D, Bird C. Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci. 1992;33:334-340.
43. Eisner A, Klein ML, Zillis JD, Watkins MD. Visual function and the subsequent development of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 1992;33:3091-3102.
44. Sunness JS, Massof RW, Johnson MA, Finkelstein D, Fine SL. Peripheral retinal function in age-related macular degeneration. Arch Ophthalmol. 1985; 103:811-816.
45. Sunness JS, Massof RW, Johnson MA, Bressler NM, Bressler SB, Fine SL. Diminished foveal sensitivity may predict the development of advanced age-related macular degeneration. Ophthalmology. 1989;96:375-381.
46. Sunness JS, Johnson MA, Massof RW, Marcus S. Retinal sensitivity over drusen and nondrusen areas: a study using fundus perimetry. Arch Ophthalmol. 1988;106:1081-1084.
47. Collins MJ. Pre-age related maculopathy and the desaturated D-15 color vision test. Clin Exp Optom. 1986;69:223-227.
48. Applegate RA, Adams AJ, Cavendar JC, Zisman F. Early color vision changes in age-related maculopathy. Appl Optics. 1987;26:1458-1462.
49. Sunness JS, Massof RW, Bressler NM, Bressler SB. S cone pathway sensitivity in eyes with high risk and low risk drusen. Appl Optics. 1989;28:1168-1161.
50. Kline DW, Schieber F. Visual aging: a transient/sustained shift? Percept Psychophys. 1981;29:181-182.
51. Kline D, Scialfa CT, Lyman BJ, Schieber F. Age differences in the temporal continuity of gratings as a function of their spatial frequency. Exp Aging Res. 1990; 16:61-65.